Chromatin accessibility profiling (ATAC-seq) revealed unique chromatin signature in depleted CD83+ microglia population compared to other microglial subpopulations.

Computational Score: 0.500 Price: $0.50 Parkinson's disease postmortem_human_tissue Status: extracted

What This Experiment Tests

Computational experiment designed to assess clinical efficacy targeting HIF1A in postmortem_human_tissue. Primary outcome: Chromatin accessibility profiling (ATAC-seq) revealed unique chromatin signature in depleted CD83+ m

Description

ATAC-seq integrated with RNA-seq data to characterize transcriptional and chromatin repertoires across microglial subpopulations

TARGET GENE

HIF1A

MODEL SYSTEM

postmortem_human_tissue

ESTIMATED COST

TIMELINE

0 months

PATHWAY

hypoxia response

SOURCE

pmid_37292857

PRIMARY OUTCOME

Chromatin accessibility profiling (ATAC-seq) revealed unique chromatin signature in depleted CD83+ microglia population compared to other microglial subpopulations.

Scoring Dimensions

Related Hypotheses (3)

Astrocyte C3aR Signaling as Bifurcation Point for A1/A2 Fate0.749

HIF1A stabilization lowers the activation threshold of circadian-disrupted microglia0.566

Moderate hyperoxia (1.5-2.0 ATA) optimally stabilizes HIF-1α to enhance VEGF-mediated angiogenesis a0.470

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.